正在加载视频...
视频加载失败
Here is an excellent answer for a question which I’m asked a lot - could there be a viable business model for a “one & done” Gene Therapy treatment and for CRISPR companies such as $PRME, $BEAM, $LLY, $NTLA, $CRSP, $CRBU, $MGX, $LCTX, $SANA and more. During his excellent... show more
0 条评论
暂无评论
原始帖子的评论将显示在这里
